Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "AI-based Surgical Robots Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.
The AI-based surgical robots market is set to reach US$ 56,738.0 Mn by 2030 from US$ 8,819.5 Mn in 2020 projecting rampant growth at a compounded annual growth rate (CAGR) of 20.7% during the forecast period from 2022 to 2030. As per the statistics provided by World Health Organization 70% of the global deaths are associated with non communicable disease.
Technological advancement in the surgical robots equipment enhanced with artificial intelligence is being currently utilized by surgeons worldwide to curb the mortality rate associated with chronic disease. Rising public health awareness and enhanced patient safety and compliance bolster the market growth for AI-based surgical robots market.
High maintenance cost associated with algorithms of robotic surgery systems and routing technology upgradation increases the demand for service products
Services are holding the largest share in the product segment for AI-based surgical robots market. High maintenance cost associated with the algorithms of robotic surgery system and routine technology upgradation increases the demand for service products. Instrument and accessories are going to register rampant growth in the near future owing to significant rise in the number of surgeries performed worldwide and huge popularity and acceptance of AI-based surgical robots system by surgeons worldwide.
Significant rise in abdominal surgeries and rising prevalence of breast cancer together increases the demand for general surgery
General surgery is reigning the application segment for AI-based surgical robots market. The major factors driving its market growth are significant rise in abdominal surgical procedures performed worldwide and rising prevalence of breast cancer. Surgeons are currently utilizing robotic assisted surgery to perform minimally invasive laparoscopic surgeries wherein few incision cuts are made using robotic arms simulated with surgeons hand movement to insert surgical equipment and a magnified camera for viewing.
Breast cancer patients are also opting for robot assisted surgery to precisely remove the cancerous cells causing minimal damage to other soft tissues. Gynecology surgical procedures using AI- based technology has garnered tremendous attention since its approval by USFDA in 2005. It is widely used to perform hysterectomy, myomectomy, sacrocolpopexy etc., ensuring optimal patient compliance and safety.
Effective collaboration between healthcare & robotics designing software companies and rising public health awareness pertaining to benefits of AI-based surgical procedures
North America is the dominating regional segment for AI-based surgical robots market representing a share of 45%. The chief contributing factors responsible for its global dominance are effective collaboration between healthcare & robotics designing software companies and rising public health awareness pertaining to benefits associated with AI-based surgical procedures. Europe is in the second place holding a market share of 30% on account of strategic collaboration between academic research institutes & hospitals pursuing diligently in developing machine learning algorithms pertaining to multidisciplinary surgical procedures. Asia Pacific is accountable for 15% market share owing to proactive government initiatives to provide funds in developing robotics technology pertaining to healthcare.
Companies developing AI-based surgical robots are Accuray Incorporated, Hansen Medical, Intuitive Surgical, Inc., MAKO, Mazor Robotics, Medrobotics Corporation, Medtech Surgical, Stereotaxis, Inc., TransEnterix and Titan Medical, Inc.
Market Segmentation
Product